Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Healthcare is generally a very defensive sector, which means that its performance is less tied to economic cycles compared to ...

Investing in strong dividend stocks is a great way to earn better-than-average long-term returns. AbbVie has a reliable, ...

Despite the pharmaceutical giant's beat-and-raise third quarter, investors were expecting better. For its third quarter, AbbVie reaped just under $15.78 billion in revenue, which was 9% higher on a ...

Strong sales from Skyrizi and Rinvoq drive AbbVie’s guidance higher, even as Humira’s role shrinks and the company ramps up US investment. AbbVie is proving it can bounce back after Humira’s US patent ...

Rated Red shows a DIY hack for building your own medicine ball. DHS in Hot Water After Posting Doctored Clip Melissa strengthens into Earth's strongest hurricane winds of 2025 US warned of problem ...

“With today’s approval, guselkumab is the first IL-23 inhibitor to offer inflammatory bowel disease patients robust clinical and endoscopic results with a fully subcutaneous induction dose regimen, ...

LOS ANGELES CAPITAL MANAGEMENT LLC increased its position in AbbVie by 304,281 shares during Q3 2025, an estimated $61.96 million trade based on the average price for Q3 2025, according to its October ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Expression of a psoriasis-associated ...

Baylor Medicine Orthopedics and Sports Medicine has opened a new location in Sugar Land and is now accepting new patients. Baylor Medicine Orthopedics and Sports Medicine offers non-operative and ...